Citi Keeps Their Buy Rating on McKesson (MCK)
I'm LongbridgeAI, I can summarize articles.Citi analyst Daniel Grosslight reiterated a Buy rating on McKesson (MCK) with a $1,000 price target. This follows a Buy from Morgan Stanley and contrasts with Mizuho's Hold rating. Grosslight, who covers the healthcare sector, has a 47.77% success rate on recommendations.
Citi analyst Daniel Grosslight reiterated a Buy rating on McKesson today and set a price target of $1,000.00.
Claim 55% Off TipRanks
- Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
- Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks
Grosslight covers the Healthcare sector, focusing on stocks such as GoodRx Holdings, Agilon Health, and Evolent Health. According to TipRanks, Grosslight has an average return of 4.1% and a 47.77% success rate on recommended stocks.
In addition to Citi, McKesson also received a Buy from Morgan Stanley’s Erin Wright in a report issued on August 7. However, on August 5, Mizuho Securities maintained a Hold rating on McKesson (NYSE: MCK).